Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02095600
Other study ID # DB-SRS
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 2011
Est. completion date July 2017

Study information

Verified date March 2019
Source Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Stereotactic lesioning of thalamus and basal ganglia for treatment of tremor is a well-known procedure which, prior to the introduction of deep brain stimulation, or DBS, was usually achieved using stereotactic surgical procedures.

Radiosurgery of invisible targets to treat movement disorders and intractable pain are still the domain of frame-based procedures, due to the need of a solid reference system registered to the anterior commissure-posterior commissure (AC-PC) line, which allows the use of stereotactic atlases.

In this study we want to utilize a mathematical method that uses atlas-derived stereotactic coordinates to perform frameless images-guided radiosurgery of such functional targets Particularly the aim of the present study is to investigate both the efficacy and the safety of the methodology to treat upper limb and hand tremor in elderly or in patients which are not ot susceptible of surgical procedures. For these reasons a dose escalation prospective trial have been designed.


Recruitment information / eligibility

Status Completed
Enrollment 6
Est. completion date July 2017
Est. primary completion date December 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- patients affected by severe upper limb tremor refractory to medical therapy and who are candidate for a deep brain stimulation (DBS) procedure.

- Age: = 18 years old

- Refusal of DBS procedure

- Written consent

Exclusion Criteria:

- Pregnancy

- Allergy to contrast medium

- DBS procedure susceptibility, if not refused

Study Design


Related Conditions & MeSH terms

  • Severe Upper Limb Tremor Refractory to Medical Therapy
  • Tremor

Intervention

Radiation:
Radiosurgical thalamotomy


Locations

Country Name City State
Italy Fondazione IRCCS Istituto Neurologico C. Besta, Unit of Radiotherapy Milan

Sponsors (1)

Lead Sponsor Collaborator
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Tremor control (improvement in FTMTRS and/or UPDRS motor) Tremor control (improvement in Fahn Tolosa Marin Tremor Rating Scale, FTMTRS, and/or Unified Parkinson's Disease Rating Scale, UPDRS, motor) 2 years
Secondary Targeting methodology validation (the lesions position, if present, will be compared to the treatment plan target position, deviations will be registered). 2 years
Secondary The treatment safety will be evaluated. Toxicity will be registered according to NCI-CTCAE v3. The treatment safety will be evaluated. Toxicity will be registered according to National Cancer Institute-Common Terminology Criteria for Adverse Events Version 3,NCI-CTCAE v3. 2 years